Implications of Accelerated Access Review

Image credit: Healthcare Times In 2014, the then Minister for Life Sciences,…


A conversation with Richard Charter

We spoke with Richard Charter, Head of Market Access & Pricing at BD…


Top 3 Trends Reshaping the Value of Surgical Robotics

With improved control over surgical instruments and a better view of the…


Core Value Dossier: One Size Fits All?

‘If all you have is a hammer, everything looks like a nail.’ This paraphrase…


A conversation with Stephan Heumann

We spoke with Stephan Heumann, Director Market Access International for Urology…


Brexit: What Can We Expect for Medical Technologies?

The United Kingdom (UK) held a referendum on June 23rd to decide whether it…


3 Steps to Increase Your ROI with Market Access Integration

The relevance of market access for medical technology companies has never been…


A conversation with Laura Figulla

We spoke with Dr. Laura Figulla, Co-Founder, CEO and Managing Director of…


Forfait Innovation: France on the Forefront of Innovation

This is the third and last post of the Conditional Reimbursement series…


Are Readmissions Profitable?

Note: This post takes the financial perspective of hospitals on readmissions.…